[文献资料]参 考 文 献

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors .Twelve vs 36 months of adjuvant imatinib as treatment of operable GIST with a high risk of recurrence：final results of a randomized trial（SSGXV Ⅲ / AIO）. ASCO annual meeting，201 ......